Page last updated: 2024-10-29

imipramine and Rett Syndrome

imipramine has been researched along with Rett Syndrome in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasaki, K1

Other Studies

1 other study available for imipramine and Rett Syndrome

ArticleYear
[Effect of tracheostomy with imipramine on apneusis attacks in a girl with Rett syndrome].
    No to hattatsu = Brain and development, 2012, Volume: 44, Issue:6

    Topics: Antidepressive Agents, Tricyclic; Child; Female; Humans; Imipramine; Respiration Disorders; Rett Syn

2012